Department Of Medicine 11
501. Amiodarone-Induced Angioedema
502. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
503. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
504. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE v survey in 16 European countries
505. Oral Microbial Signature of Rheumatoid Arthritis in Female Patients
506. Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review
507. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study
508. In-situ, real-time monitoring of thermo-mechanical properties of biological tissues undergoing laser heating and ablation
509. Thermo-Visco-Elastometry of RF-Wave-Heated and Ablated Flesh Tissues Containing Au Nanoparticles
510. Prevalence of migraine in individuals with functional seizures: A systematic review and meta-analysis
511. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
512. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
513. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
514. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
515. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
516. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
517. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
518. Inositols in the ovaries: activities and potential therapeutic applications
519. Menstrual cycle changes after COVID-19 vaccination or infection: Not two sides of the same coin
520. Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?
521. A global action agenda for turning the tide on fatty liver disease
522. A global action agenda for turning the tide on fatty liver disease
523. A global action agenda for turning the tide on fatty liver disease
524. A global action agenda for turning the tide on fatty liver disease
525. A global action agenda for turning the tide on fatty liver disease
526. A global action agenda for turning the tide on fatty liver disease
527. A global action agenda for turning the tide on fatty liver disease
528. A global action agenda for turning the tide on fatty liver disease
529. A global action agenda for turning the tide on fatty liver disease
530. Advancing the global public health agenda for NAFLD: a consensus statement
531. Advancing the global public health agenda for NAFLD: a consensus statement
532. Advancing the global public health agenda for NAFLD: a consensus statement
533. Advancing the global public health agenda for NAFLD: a consensus statement
534. Advancing the global public health agenda for NAFLD: a consensus statement
535. Advancing the global public health agenda for NAFLD: a consensus statement
536. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
537. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
538. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
539. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
540. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
541. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
542. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
543. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
544. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
545. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
546. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
547. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
548. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
549. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
550. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
1 9 10 11 12 13 24